James G McLarnon Selected Research

James G McLarnon Research Topics

Disease

17	Alzheimer Disease (Alzheimer's Disease) 12/2021 - 02/2005
9	Gliosis 08/2015 - 10/2004
5	Glioma (Gliomas) 01/2017 - 02/2008
5	Inflammation (Inflammations) 01/2011 - 05/2007
4	Vascular Remodeling 03/2013 - 02/2008
4	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2013 - 08/2007
3	Neuroinflammatory Diseases 12/2021 - 01/2012
3	Neoplasms (Cancer) 01/2017 - 12/2009
3	Huntington Disease (Huntington's Disease) 06/2004 - 10/2003
2	Brain Neoplasms (Brain Tumor) 01/2017 - 01/2011
2	Neuroblastoma 01/2011 - 10/2002
1	Brain Injuries (Brain Injury) 01/2016
1	Wounds and Injuries (Trauma) 06/2011
1	Infections 12/2009
1	Atherosclerosis 06/2009
1	Parkinson Disease (Parkinson's Disease) 08/2007
1	Neutropenia 03/2007
1	Nervous System Diseases (Neurological Disorders) 12/2005

Drug/Important Bio-Agent (IBA)

12	Peptides (Polypeptides)IBA 08/2015 - 10/2004
6	Purinergic Receptors (Receptors, Purine)IBA 01/2017 - 11/2006
4	Quinolinic AcidIBA 05/2008 - 10/2003
3	Fibrinogen (Factor I)FDA Link 12/2021 - 09/2009
3	Adenosine Triphosphate (ATP)IBA 01/2017 - 11/2006
3	Pyruvic Acid (Pyruvate)IBA 01/2016 - 10/2003
3	Interleukin-8 (Interleukin 8)IBA 08/2015 - 02/2005
3	LigandsIBA 08/2015 - 08/2007
3	ChemokinesIBA 08/2015 - 02/2005
3	CalciumIBA 06/2011 - 08/2005
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2011 - 02/2008
3	amyloid beta-protein (1-42)IBA 09/2009 - 11/2006
3	Amyloid beta-PeptidesIBA 01/2009 - 02/2005
2	Purinergic P2X7 ReceptorsIBA 01/2017 - 02/2008
2	Phosphates (Orthophosphate)IBA 08/2015 - 03/2013
2	Amyloid (Amyloid Fibrils)IBA 01/2011 - 01/2011
2	coomassie Brilliant BlueIBA 01/2011 - 11/2008
2	CytokinesIBA 12/2009 - 10/2002
2	NeurotoxinsIBA 05/2008 - 03/2007
1	Thrombin FDA Link 12/2021
1	FibrinIBA 12/2021
1	SB-332235IBA 08/2015
1	Interleukin-8B ReceptorsIBA 08/2015
1	BuffersIBA 03/2013
1	AngiostatinsIBA 03/2013
1	Proto-Oncogene Protein c-ets-1IBA 01/2013
1	Chemotactic FactorsIBA 01/2012
1	methylthio-ADPIBA 06/2011
1	SolutionsIBA 06/2011
1	N(6)-methyl-2'-deoxyadenosine 3',5'-diphosphateIBA 06/2011
1	pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acidIBA 06/2011
1	1- (2- (3- (4- methoxyphenyl)propoxy)- 4- methoxyphenylethyl)- 1H- imidazoleIBA 06/2011
1	2-methylthioadenosineIBA 06/2011
1	pyrazoleIBA 01/2011
1	acetamideIBA 01/2011
1	Conditioned Culture MediaIBA 01/2011
1	3'-O-(4-benzoyl)benzoyladenosine 5'-triphosphateIBA 01/2011
1	triphosphoric acid (triphosphate)IBA 01/2011
1	Green Fluorescent ProteinsIBA 12/2009
1	Lysophosphatidylcholines (Lysophosphatidylcholine)IBA 06/2009
1	oxidized low density lipoproteinIBA 06/2009
1	Phospholipids (Phosphatides)FDA LinkGeneric 06/2009
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2009
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2008
1	cyclo-VEGIIBA 05/2008
1	Thalidomide (Thalomid)FDA Link 02/2008
1	Cysteine Proteinase InhibitorsIBA 12/2005
1	Cystatin CIBA 12/2005
1	Cysteine Proteases (Cysteine Protease)IBA 12/2005
1	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 06/2004
1	Nuclear Antigens (Extractable Nuclear Antigens)IBA 06/2004
1	CalbindinsIBA 06/2004
1	Free RadicalsIBA 05/2004
1	Neuroprotective AgentsIBA 10/2003
1	Cytokine Receptors (Cytokine Receptor)IBA 10/2002
1	TubulinIBA 10/2002

Therapy/Procedure

3	Transplantation 01/2013 - 06/2004
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2013
1	Deep Brain Stimulation 01/2013
1	Therapeutics 01/2013
1	Intravenous Administration 01/2011
1	Cell Transplantation 12/2009